Skip Navigation

What Types of Prenatal Screening Are Available?

Prenatal diagnosis for Pompe disease is available for families with an affected child who are pregnant with another child. In fact, Pompe disease was one of the first genetic disorders researchers tried to diagnose before birth using amniocentesis, beginning in the late 1960s. Amniocentesis is a procedure in which a needle is inserted into the mother's abdomen to withdraw fluid from the sac that encloses the fetus.

Today, prenatal diagnosis can be made by testing cells obtained by amniocentesis or, more commonly, the direct enzyme analysis of uncultured chorionic villi cells. Chorionic villi cells stick out from the fetus's outer membrane and combine with the tissue of the mother's uterus to form the placenta.

The chorionic villi examination has become the more preferable of the two tests as it allows for early diagnosis (as soon as the 12th week of pregnancy) and a generally quick turnaround for results. Further research is being done to explore other early testing methods, such as newborn screening.

Ask a medical question Pompe Registry

Contact

Genzyme

500 Kendall Street
Cambridge, MA 02142
617 768 9000
800 745 4447

Genzyme Europe BV

Gooimeer 10
1411 DD Naarden
The Netherlands
31 35 699 1200